Your browser does not support JavaScript!

Author: Tronserve admin

Thursday 5th August 2021 12:35 PM

Medical 3D Printing Firm Raises $3 Million to Support US Expansion


image cap
147 Views

axial3D, a trusted medical 3D printing firm, has launched the closing of a USD $3 million funding round. The pioneering company is building an automatic 3D printing solution for the healthcare sector that is dramatically advancing the standards and efficiency of surgery worldwide.

 

The funding round was led by London-based Imprimatur Capital Fund Management, an international science and technology buyer. The round was also supported by a U.S. investment consortium containing of a number of surgical angel people. axial3D's previous institutional investors, Techstart Ventures, Clarendon Fund Managers and Innovation Ulster Ltd, also took part in the round. The investment will support axial3D's rapid progress plans for the USA. The company plans to open an office in the region, following past customer wins and as other healthcare institutions sign up to the service. The firm is initiating roles within the expanding U.S. market and at its base in Belfast to maintain the large growth and ensure continuous innovation.

 

There's a big highlight on widening its machine learning team, which builds groundbreaking automated algorithms that make access to medical 3D printing better than ever for hospitals. Daniel Crawford, CEO at axial3D, said, "The closure of this investment round marks an important milestone for our company. It will accelerate our growth within our increasing markets and enable us to bring our 3D printing solution to more healthcare organizations, helping them to drive down costs, improve compliance and, ultimately, enhance patient care." He continued, "Continuous innovation is crucial to bring the best solutions to market and keep up with customer requirements. Following our recent collaborations with Tallahassee Memorial Healthcare and University Hospital Basel, we will highlight further on the North American and European markets. This includes opening an office in the USA and recruiting more talent into our team, particularly to grow our machine learning capability. This will enable us to continue to innovate and find new ways to bring 3D printing on-demand to the entire healthcare sector." Dr. Christopher Rumana, Neurosurgeon & Charmain of the Board at Tallahassee Memorial Healthcare (TMH), has been a user of axial3D's medical 3D printing service since 2018 and is part of the cohort who are now investing in the company. "axial3D has built a scalable, accessible platform for clinicians to access 3D printing without the capital expenditure or manpower usually required. Having been in the medical field for over two decades, I have seen how technology boosts patient care. With TMH being a user of axial3D's service, our own patients have been favorably afflicted by the use of 3D printing. I want to see this service adopted in more healthcare institutions across the USA so that everyone who needs it can profit from the technology."

 

Since 2011, Dr. Rumana has been a representative of the Board of Directors at Tallahassee Memorial Hospital, where he at this time serves as the Chairman of the Board. The global 3D printing medical devices market is expected to see a compounding annual growth rate of 23%, largely due to the increasing adoption of 3D printing technology within the medical sector. axial3D has a range of solutions for healthcare institutions at every stage of their 3D printing journey, from those wanting a one-off custom print, to those with an ongoing 3D print lab hoping to increase compliance and productivity, while reducing operating costs.



This article is originally posted on manufacturingtomorrow.com


Share this post:


This is the old design: Please remove this section after work on the functionalities for new design

Posted on : Thursday 5th August 2021 12:35 PM

Medical 3D Printing Firm Raises $3 Million to Support US Expansion


none
Posted by  Tronserve admin
image cap

axial3D, a trusted medical 3D printing firm, has launched the closing of a USD $3 million funding round. The pioneering company is building an automatic 3D printing solution for the healthcare sector that is dramatically advancing the standards and efficiency of surgery worldwide.

 

The funding round was led by London-based Imprimatur Capital Fund Management, an international science and technology buyer. The round was also supported by a U.S. investment consortium containing of a number of surgical angel people. axial3D's previous institutional investors, Techstart Ventures, Clarendon Fund Managers and Innovation Ulster Ltd, also took part in the round. The investment will support axial3D's rapid progress plans for the USA. The company plans to open an office in the region, following past customer wins and as other healthcare institutions sign up to the service. The firm is initiating roles within the expanding U.S. market and at its base in Belfast to maintain the large growth and ensure continuous innovation.

 

There's a big highlight on widening its machine learning team, which builds groundbreaking automated algorithms that make access to medical 3D printing better than ever for hospitals. Daniel Crawford, CEO at axial3D, said, "The closure of this investment round marks an important milestone for our company. It will accelerate our growth within our increasing markets and enable us to bring our 3D printing solution to more healthcare organizations, helping them to drive down costs, improve compliance and, ultimately, enhance patient care." He continued, "Continuous innovation is crucial to bring the best solutions to market and keep up with customer requirements. Following our recent collaborations with Tallahassee Memorial Healthcare and University Hospital Basel, we will highlight further on the North American and European markets. This includes opening an office in the USA and recruiting more talent into our team, particularly to grow our machine learning capability. This will enable us to continue to innovate and find new ways to bring 3D printing on-demand to the entire healthcare sector." Dr. Christopher Rumana, Neurosurgeon & Charmain of the Board at Tallahassee Memorial Healthcare (TMH), has been a user of axial3D's medical 3D printing service since 2018 and is part of the cohort who are now investing in the company. "axial3D has built a scalable, accessible platform for clinicians to access 3D printing without the capital expenditure or manpower usually required. Having been in the medical field for over two decades, I have seen how technology boosts patient care. With TMH being a user of axial3D's service, our own patients have been favorably afflicted by the use of 3D printing. I want to see this service adopted in more healthcare institutions across the USA so that everyone who needs it can profit from the technology."

 

Since 2011, Dr. Rumana has been a representative of the Board of Directors at Tallahassee Memorial Hospital, where he at this time serves as the Chairman of the Board. The global 3D printing medical devices market is expected to see a compounding annual growth rate of 23%, largely due to the increasing adoption of 3D printing technology within the medical sector. axial3D has a range of solutions for healthcare institutions at every stage of their 3D printing journey, from those wanting a one-off custom print, to those with an ongoing 3D print lab hoping to increase compliance and productivity, while reducing operating costs.



This article is originally posted on manufacturingtomorrow.com

Tags:
medical 3d printing united states expansion